Lincoln National Corp’s Chemed CHE Stock Holding History

Lincoln National Corp’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,412	Closed	-$452K	–	563
2019 Q1	$452K	Buy	+1,412	New	+$434K	0.02%	314

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Lincoln National Corp's CHE Position: Q2 2019 in Review

Lincoln National Corp sold out of Chemed (CHE) in Q2 2019, closing a stake of 1,412 shares — an estimated $452K sold.

Lincoln National Corp first reported a position in CHE in Q1 2019 and held it in 1 quarter. The position peaked at $452K in Q1 2019. 370 funds tracked by Wall St. Rank hold CHE as of Q2 2019.

Lincoln National Corp reported no remaining Chemed position as of Q2 2019 after selling out during the quarter.
Lincoln National Corp sold 1,412 Chemed shares in Q2 2019, an estimated $452K.
Lincoln National Corp first reported a position in Chemed in Q1 2019 and held it in 1 quarter.
Lincoln National Corp's Chemed position peaked at $452K in Q1 2019.
370 funds tracked by Wall St. Rank held Chemed as of Q2 2019.

Based on Lincoln National Corp's 13F filing for Q2 2019, filed 6 Aug 2019.